Buy Max Healthcare Institute; target of Rs 1080: Prabhudas Lilladher

Moneycontrol • 1 day ago

Original source

Key Investment Pillars

  • New bed additions and brownfield expansions are driving growth, with 202 brownfield beds added in Q2FY27.
  • The company's operational efficiency has been commendable, especially in competitive markets like NCR.
  • Oncology growth is expected to improve from Q3FY27 on a lower base.
  • The company's net debt/EBITDA ratio is below 1, indicating a healthy balance sheet.

Thesis Validation Checklist

  • Investors should watch for further ramp-up of brownfield and greenfield units, including the 500-bed Gurugram greenfield project.
  • Improvement in oncology growth and ARPP (Average Revenue Per Patient) is expected to drive revenue growth.
  • The company's ability to maintain its operational efficiency and manage costs will be crucial in achieving its growth targets.
  • Any changes in the regulatory environment, such as CGHS price revisions, could impact the company's revenue and profitability.